-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Structure Therapeutics, Lowers Price Target to $100

Benzinga·03/16/2026 16:13:36
Listen to the news
HC Wainwright & Co. analyst Ananda Ghosh maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price target from $114 to $100.